The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index, and 2 are not checked yet; none of the 12 sources its claims cite is checked for support yet.
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Open accessAbstract
Following its emergence in late 2019, the spread of SARS-CoV-2 1,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail 3-5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.
Checked 2026-10-06 · 2 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
41 Own result · 24 Own interpretation · 11 Own method · 8 Not checked yet · 7 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Norway and Iceland, for example, seem to have only a small number of introductions over the summer that led to substantial further spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, countries like Switzerland, the Netherlands, or the United Kingdom have sampled sequences that correspond to a large number of independent introductions that include most major genotypes observed in Spain.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most basal genotypes have been observed both in Spain and a large number of other countries, suggesting repeated exports.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequences from Hong Kong, Australia, New Zealand, and Singapore, presumably exports from Europe, were first detected between mid-August and mid-October (see Supplementary Table I).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The dose-response curves were indistinguishable for the SARS-CoV-2 2PS and the SARS-CoV-2 2P A222V D614G S ectodomain trimers (observed by ELISA, Fig. ED3a-d)”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In many European countries, we observe a gradual rise starting in mid-July before settling at a level between 15 and 80% in September or October.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several other smaller clusters defined by the spike mutations D80Y, S98F, N439K are also seen in multiple countries (see Table ED I and Fig. ED1).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to S:A222V, 20E (EU1) has the amino acid mutations ORF10:V30L, N:A220V and ORF14:L67F.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Epidemiological data from Spain indicates the earliest sequences in the cluster are associated with two known outbreaks in the north-east of the country.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By the end of August, 20E (EU1) also included sequences from Belgium, Switzerland, France, Denmark, the UK, Germany, Latvia, Sweden, Norway and Italy.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 8
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The tree indicates that 20E (EU1) harbors substantial diversity and most major genotypes have been observed in many European countries.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In Fig. ED4a, the majority of sequences from these countries fall into one sector, the remainder are singletons or very small clusters that have not spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Throughout July and August 2020, Spain had a higher per capita incidence than most other European countries (see Fig ED5) and 20E (EU1) was much more prevalent in Spain then elsewhere, suggesting Spain as likely origin of most 20E (EU1) introductions to other countries.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lentiviral particles with the A222V mutant spike had slightly higher titers than those without (mean 1.3-fold higher), although the difference was not statistically significant after normalization by p24 concentration (Fig. ED3e-h).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“20E (EU1) first rose in frequency in Spain, jumping to around 50% prevalence within a month of the first sequence being detected before rising to 80%.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Early observations of 20E (EU1)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“S:N439K is present in two larger clusters found across Europe 19 and arose several times independently.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
What the sources say
- Not checked yetcites [19] Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171–1187 (2021). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Similarly, for Germany and Switzerland we would expect around 320 and 90 introductions of 20E (EU1), respectively.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Returning tourists have a similar SARS-CoV-2 incidence to the reported provincial incidence in Spain.
- The authors state this as an assumption: Reported provincial incidence in Spain is accurate and representative for the import model.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While there is little data to inform estimates of R e for 20E (EU1) in July and it differs little from the prior, there is some evidence that 20E (EU1) was growing faster than other variants in August.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A novel variant (orange; 20E (EU1)) with mutation S:A222V on a S:D614G background emerged in early summer and is common in most countries with recent sequences.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were also a small number of larger transmission chains including more than 53 transmissions (20 across all data sets) which are not shown in the histograms.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After p24 normalization, the titer difference shrinks fom 1.28 to 1.14 fold, increasing the p-value to 0.16.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Pseudotyped Lentivirus Production and Titering
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The number of confirmed SARS-CoV-2 cases in Spain rose from around 10 cases per 100k inhabitants per week in early July to 100 in late August, while case numbers remained low in most of Europe during this time.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Notably, the peak in August in the Swiss analysis is larger under the 'min' definition (f) than under the 'max' definition (e), consistent with a more conservative definition of a cluster which would then require more onward transmission.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“From 1 June 2020 to 30 September 2020, the Swiss Federal Office of Public Health (FOPH) reported 23,199 confirmed SARS-CoV-2 cases.14,583 (62.9%) cases provided information about their likely place of exposure and country of infection in a clinical registration form.Of these, 3,304 (22.7%) reported an exposure abroad and 136 (0.9%) named Spain as the country of infection.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Estimation of contributions from imports
plainn = 23,199- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After sub-sampling, the 20E (EU1) cluster within the Nextstrain build contains 5,145 sequences, 3,369 of which are unique (accounting for Ns).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogenetic analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Switzerland reported 131 infections in travel returnees, while the model predicts 130.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Travel resumed quickly and peaked during July and August, see Fig. 3.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The substitution A222V in spike has no substantial effect on antigenic properties (a-d) and replication of pseudotyped lentiviruses (e-h).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In Europe, we see 206 20E (EU1) singletons (46% of all 20E (EU1) introductions).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While initial introductions of the variant likely originated from Spain, 20E (EU1) cases outside of Spain surpassed those in Spain in late September and later cross-border transmissions likely originated in other countries (see Fig ED5 B).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Different mutations between positions 180 and 220 in N are observed in almost every major lineage and we are not aware of any evidence suggesting that these mutations have important phenotypic consequence.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Characterization of S:A222V
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Residue S477 is close to the receptor binding site (Fig ED2) and part of the epitope recognized by the S2E12 and C102 neutralizing antibodies 17,18 .”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Abstract
What the sources say
- Not checked yetcites [17] Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682–687 (2020). source
- Not checked yetcites [18] Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science 370, 950–957 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite limitations in sampling, Fig. ED4a clearly shows that most major genotypes in this cluster were distributed to multiple countries, suggesting that identical genotypes were introduced into many countries .”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: The majority of mutations observed in the tree arose once and were carried between countries.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The variant seems to have initially spread among agricultural workers in Aragon and Catalonia, then moved into the local population, where it was able to travel to the Valencia Region and on to the rest of the country.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Expansion and spread across Europe
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, countries where 20E (EU1) was rare (Belgium, France, Czech Republic, Fig. ED1) have seen similarly rapid increases, suggesting that this rise was not driven by any particular lineage and that 20E (EU1) has no substantial difference in transmissibility.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The fact that the rapid increase of the frequency of 20E (EU1) slowed or stopped in most countries after the summer travel period and didn't fully replace other variants is consistent with import driven dynamics with little or no competitive advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Though the jitter means branch lengths should be interpreted with caution, the smallest branches shown in the tree equal to 1 mutation.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Pseudotyped Lentivirus Production and Titering
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“It is important to remember that, particularly for countries other than the UK, the full circulating diversity of the variant is probably not being captured, thus intermediate transmissions cannot be ruled out.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogeny and Geographic Distribution
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries like Norway and Iceland have relatively few clusters, with one or two large clusters dominating, suggesting a small number of introductions dominated 20E (EU1) circulation.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“They are not in the database of commonly misidentified cell lines.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Enzyme-linked immunosorbent assay (ELISA)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries with small (1-4 fold) and large (8-12 fold) discrepancies tend to visit distinct destinations in Spain, see Figs.ED6 and ED7(c-e), further suggesting that underestimation of incidence in travel returnees is determined by destination and behavior.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This selection will exclude any sequences with no coverage or reversions at these positions, but the similarity-based sampling during the Nextstrain run will identify these, as well as any other nearby sequences, and incorporate them into the dataset.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Defining the 20E (EU1) Cluster
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, we excluded several problematic sequences due to high intra-sample variation, wrong dates, and over-divergence (divergence values are implausible given the provided dates).”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Defining the 20E (EU1) Cluster
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Travel precautions such as quarantine should in principle have prevented spread of SARS-CoV-2 infections acquired abroad, but in practice failed to have the desired effect.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Countries like the UK and Denmark, on the other hand, show many clusters of varying size, indicating multiple introductions that led to onward spread.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While we cannot rule out that 20E (EU1) has a slight transmission advantage compared to other variants circulating at the time, most of its spread is explained by epidemiological factors.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In case of 20E (EU1) none of these seem to have changed substantially, making it an important example of how travel combined with large regional differences in prevalence can lead to substantial rapid shifts in the variant distribution without a dramatic transmission advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Discussion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In such a high incidence setting, travel alone cannot explain a rapid rise in frequency and the dynamics points to a bona fide transmission advantage.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The experiment shown is representative of two independent experiments.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This tree allows us to infer lower bounds for the number of introductions to each country, and to identify plausible origins of those introductions.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Phylogeny and Geographic Distribution
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such association with particular demographics will decay rapidly and with it any associated increased transmission inferred by phylodynamics.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > A C C E L E R A T E D A R T I C L E P R E V I E W
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Gibco (Fisher) Expi293F Cells were used for protein production and have not been authenticated or tested for mycoplasma contamination.”
§ Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 > Enzyme-linked immunosorbent assay (ELISA)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The authors state this as an assumption.
Returning tourists have a similar SARS-CoV-2 incidence to the reported provincial incidence in Spain.
“assuming that returning tourists have a similar incidence”
The authors state this as an assumption.
20E (EU1) spread at the same rate as other variants in the resident countries.
“This model assumes that 20E (EU1) spread at the same rate as other variants in the resident countries”
The authors state this as an assumption.
The majority of mutations observed in the tree arose once and were carried between countries.
“it is reasonable to assume that the majority of mutations observed in the tree arose once and were carried (possibly multiple times) between countries.”
The authors state this as an assumption.
Reported provincial incidence in Spain is accurate and representative for the import model.
“Taking reported incidence in the provinces at face value”
The authors state this as an assumption.
20E (EU1) and non-20E (EU1) variants share a sampling probability.
“20E (EU1) and non-20E (EU1) variants share a sampling probability”
The paper relies on this without support.
Observed frequencies are subject to variable reporting delays.
“Observed frequencies are subject to variable reporting delays.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the decline in the number of cases by June, 2020 led governments in Europe to rescind control measures and to encourage a return to life as usual, especially in the context of Europe's upcoming summer holidays; this relaxing of control measures led to another wave of infections in countries across Europe in September, 2020.”
From The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) · cites this paper as [180]
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era
(2019) · doi:10.1101/849372 · Cited by 16,873
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Self-citationBEAST 2.5: An advanced software platform for Bayesian evolutionary analysis
Bouckaert, R., Vaughan, T. G., Barido-Sottani, J., Duchêne, S., Fourment, M., Gavryushkina, A., Heled, J., Jones, G., Kühnert, D., De Maio, N., et al. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006650 · Cited by 4,556
Self-citationKorber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Self-citationGISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Research works printed but not linked: 1
- Pearson, C. A. B. et al. Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa. Preprint at https://cmmid.github.io/topics/covid19/sa-novel-variant.html (2021).
Cited by
Sorted by citations
Items 101–200 of 605
The past, current and future epidemiological dynamic of SARS-CoV-2
Balloux, F., Tan, C. C. S., Swadling, L., Richard, D., Jenner, C., Maini, M. K., & van Dorp, L. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac003 · Cited by 41
Ferrari, M., Mekkaoui, L., Ilca, F. T., Akbar, Z., Bughda, R., Lamb, K., Ward, K., Parekh, F., Karattil, R., Allen, C. G., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00685-21 · Cited by 37
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
Tan, Z. W., Tee, W.-V., Samsudin, F., Guarnera, E., Bond, P. J., & Berezovsky, I. N. (2022) · Structure · doi:10.1016/j.str.2021.12.011 · Cited by 38
Clinical metagenomics for diagnosis and surveillance of viral pathogens
Montaguth, O. E. T., Buddle, S., Morfopoulou, S., & Breuer, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01223-5 · Cited by 37
Lee, K., Grépin, K. A., Worsnop, C. Z., Marion, S., Piper, J., & Song, M. (2021) · Globalization and Health · doi:10.1186/s12992-021-00709-0 · Cited by 36
Ginex, T., Marco‐Marín, C., Wieczór, M., Mata, C. P., Krieger, J., Ruiz-Rodríguez, P., Lopez-Redondo, M., Francés‐Gómez, C., Melero, R., Sorzano, C. Ó. S., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010631 · Cited by 36
Self-citationReversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
Philip, A. M., Ahmed, W. S., & Biswas, K. H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.019 · Cited by 35
Miller, A., Leach, A., Thomas, J. C., McAndrew, C., Bentley, E. M., Mattiuzzo, G., John, L., Mirazimi, A., Harris, G., Gamage, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89957-z · Cited by 34
Tracing Transmission of Sin Nombre Virus and Discovery of Infection in Multiple Rodent Species
Goodfellow, S. M., Nofchissey, R. A., Schwalm, K. C., Cook, J. A., Dunnum, J. L., Guo, Y., Ye, C., Mertz, G. J., Chandran, K., Harkins, M., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01534-21 · Cited by 34
Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro
Pucci, F., & Rooman, M. J. (2021) · Viruses · doi:10.3390/v13050935 · Cited by 35
Showers, W. M., Leach, S. M., Kechris, K. J., & Strong, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105153 · Cited by 35
Zhao, Y., Ni, W., Liang, S., Dong, L., Xiang, M., Cai, Z., Niu, D., Zhang, Q., Wang, D., Zheng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3332 · Cited by 34
SARS-CoV-2 Variants Detection Using TaqMan SARS-CoV-2 Mutation Panel Molecular Genotyping Assays
Neopane, P., Nypaver, J., Shrestha, R., & Beqaj, S. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s335583 · Cited by 33
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
Klink, G. V., Safina, K. R., Nabieva, E., Shvyrev, N., Garushyants, S. K., Alekseeva, E. I., Komissarov, A. B., Danilenko, D., Pochtovyi, A. A., Divisenko, E. V., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac017 · Cited by 33
Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada
McLaughlin, A., Montoya, V., Miller, R. L., Mordecai, G. J., Worobey, M., Poon, A. F. Y., & Joy, J. B. (2022) · eLife · doi:10.7554/elife.73896 · Cited by 33
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Lee, B., Quadeer, A. A., Sohail, M. S., Finney, E., Ahmed, S. F., McKay, M. R., & Barton, J. P. (2025) · Nature Communications · doi:10.1038/s41467-024-55593-0 · Cited by 32
Ward, D., Higgins, M. K., Phelan, J. E., Hibberd, M. L., Campino, S. G., & Clark, T. G. (2021) · Genome Medicine · doi:10.1186/s13073-020-00822-6 · Cited by 33
Brüssow, H. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13916 · Cited by 32
Delay-differential SEIR modeling for improved modelling of infection dynamics
Kiselev, I. N., Akberdin, I. R., & Kolpakov, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40008-9 · Cited by 33
Troyano-Hernáez, P., Reinosa, R., & Holguín, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126394 · Cited by 32
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877 · Cited by 31
A Conceptual Model for Geo-Online Exploratory Data Visualization: The Case of the COVID-19 Pandemic
Bernasconi, A., & Grandi, S. (2021) · Information · doi:10.3390/info12020069 · Cited by 30
SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions
Torrens‐Fontanals, M., Peralta-García, A., Talarico, C., Guixà-González, R., Toni Giorgino, A., & Selent, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab977 · Cited by 30
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data
Nadeau, S., Vaughan, T. G., Beckmann, C., Topolsky, I., Chen, C., Hodcroft, E. B., Schär, T., Nissen, I., Santacroce, N., Burcklen, E., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn7979 · Cited by 30
Self-citationThe first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2
Wassenaar, T. M., Wanchai, V., Buzard, G. S., & Ussery, D. W. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac003 · Cited by 29
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
Chaqroun, A., Hartard, C., & Schvoerer, É. (2021) · Viruses · doi:10.3390/v13061171 · Cited by 31
Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols
Brejová, B., Boršová, K., Hodorová, V., Čabanová, V., Gafurov, A., Fričová, D., Neboháčová, M., Vinař, T., Klempa, B., & Nosek, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259277 · Cited by 31
Chouikha, A., Farès, W., Lamari, A., Boubaker, S., Belaiba, Z., Ghedira, K., Rebai, W. K., Ayouni, K., Khedhiri, M., Halima, S. B., et al. (2022) · Viruses · doi:10.3390/v14030624 · Cited by 29
Santos, J. D., Sobral, D., Pinheiro, M. M., Isidro, J., Bogaardt, C., Pinto, M., Eusébio, R., Santos, A., Mamede, R., Horton, D. L., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01334-3 · Cited by 28
Molina-Mora, J. A., Cordero-Laurent, E., Godínez, A., Calderón-Osorno, M., Brenes, H., Soto-Garita, C., Pérez-Corrales, C., Rica, C.-C. C. I. D. E. G. D. S.-C.-2. C., Drexler, J. F., Moreira‐Soto, A., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104872 · Cited by 29
First evidence of human‐to‐dog transmission of SARS‐CoV‐2 B.1.160 variant in France
Medkour, H., Catheland, S., Boucraut‐Baralon, C., Laidoudi, Y., Sérémé, Y., Pingret, J., Million, M., Houhamdi, L., Levasseur, A., Cabassu, J., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14359 · Cited by 28
Alteri, C., Scutari, R., Costabile, V., Colagrossi, L., Rosa, K. Y. L., Agolini, E., Lanari, V., Chiurchiù, S., Romani, L., Markowich, A. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14426-0 · Cited by 28
Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafari, M., et al. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2023.1284 · Cited by 28
Bedotto, M., Fournier, P., Houhamdi, L., Levasseur, A., Delerce, J., Pinault, L., Padane, A., Chamieh, A., Tissot‐Dupont, H., Brouqui, P., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104814 · Cited by 27
Molina-Mora, J. A., González, A., Morgan, S. J., Cordero-Laurent, E., Brenes, H., Soto-Garita, C., Sequeira-Soto, J., & Duarte-Martínez, F. (2022) · Phenomics · doi:10.1007/s43657-022-00058-x · Cited by 27
Hospitalization burden and epidemiology of the COVID-19 pandemic in Spain (2020–2021)
Carretero, R. G., Gómez, O. V., Gil-Prieto, R., & de Miguel, Á. G. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08454-y · Cited by 27
Enhanced deep Convolutional Neural Network for SARS-CoV-2 variants classification
Awe, O. I., Obura, H. O., Charles, S., Mudibo, E. O., & Mwanga, M. J. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1512003 · Cited by 28
Sokhansanj, B. A., Zhao, Z., & ROSEN, G. L. (2022) · Biology · doi:10.3390/biology11121786 · Cited by 27
Data-driven analysis of amino acid change dynamics timely reveals SARS-CoV-2 variant emergence
Bernasconi, A., Mari, L., Casagrandi, R., & Ceri, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00496-z · Cited by 26
COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves
Fericean, R. M., Roșca, O., Cîtu, C., Manolescu, D., Bloancă, V., Toma, A.-O., Boeriu, E., Dumitru, C., Ravulapalli, M., Barbos, V., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226803 · Cited by 26
SARS-CoV-2 and COVID-19: A Narrative Review
Blann, A. D., & Heitmar, R. (2022) · British Journal of Biomedical Science · doi:10.3389/bjbs.2022.10426 · Cited by 25
COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome
Nagy, Á. M., Ligeti, B., Szebeni, J., Pongor, S., & Győrffy, B. (2021) · Database · doi:10.1093/database/baab020 · Cited by 25
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Aggarwal, D., Page, A. J., Schaefer, U., Savva, G. M., Myers, R. E., Volz, E., Ellaby, N. A. F., Platt, S., Groves, N., Gallagher, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28371-z · Cited by 25
Potdar, V. A., Vipat, V., Ramdasi, A. Y., Jadhav, S., Pawar-Patil, J., Walimbe, A. M., Patil, S., Choudhury, M. L., Shastri, J. S., Agrawal, S. R., et al. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_3418_20 · Cited by 24
Smith, M. R., Trofimova, M., Weber, A., Duport, Y., Kühnert, D., & von Kleist, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26267-y · Cited by 24
Coronavirus GenBrowser for monitoring the transmission and evolution of SARS-CoV-2
Yu, D., Yang, X. Y., Tang, B., Pan, Y.-H., Yang, J., Duan, G., Zhu, J., Hao, Z.-Q., Mu, H., Dai, L., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab583 · Cited by 24
Andrés, C., Piñana, M., Borràs-Bermejo, B., Gónzalez‐Sánchez, A., García‐Cehic, D., Esperalba, J., Rando‐Segura, A., Zules-Oña, R., de Campos, C. F., Codina, M. G., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2011617 · Cited by 26
Tracing transmission of Sin Nombre Virus and discovery of infection in multiple rodent species
Goodfellow, S. M. (2021) · UNM’s Digital Repository (University of New Mexico) · Cited by 23
Oh, D., Hölzer, M., Paraskevopoulou, S., Trofimova, M., Hartkopf, F., Budt, M., Wedde, M., Richard, H., Haldemann, B., Domaszewska, T., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac399 · Cited by 23
Eales, O. D., Page, A. J., Martins, L. D. O., Wang, H., Bodinier, B., Haw, D., Jonnerby, J., Atchison, C. J., Robson, S. C., Connor, T. R., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07628-4 · Cited by 23
Alam, A. S. M. R. U., Islam, O. K., Hasan, M. S., Islam, M. R., Mahmud, S., Al‐Emran, H. M., Jahid, I. K., Crandall, K. A., & Hossain, M. A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27416 · Cited by 24
Stadtmüller, M., Laubner, A., Rost, F., Winkler, S., Patrasová, E., Šimůnková, L., Reinhardt, S., Beil, J., Dalpke, A. H., & Yi, B. (2022) · Virus Evolution · doi:10.1093/ve/veac010 · Cited by 24
Efficient Approximate Kernel Based Spike Sequence Classification
Ali, S., Sahoo, B., Khan, M. A., Zelikovsky, A., Khan, I., & Patterson, M. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3206284 · Cited by 23
RETRACTED: Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database
Zelenova, M. A., Ivanova, A., Semyonov, S., & Gankin, Y. V. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104981 · Cited by 22
RetractedSemantic interoperability: ontological unpacking of a viral conceptual model
Bernasconi, A., Guizzardi, G., Pastor, Ó., & Storey, V. C. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-05022-0 · Cited by 22
RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies
Caniego-Casas, T., Martínez-García, L., Alonso, M., Pizarro, D., Carretero‐Barrio, I., Castro, N. M., Ruz‐Caracuel, I., de Pablo, R., Sáiz, A., Royo, R. N., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.824967 · Cited by 22
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneckPreprint
Braun, K. M., Moreno, G. K., Halfmann, P., Hodcroft, E. B., Baker, D. A., Boehm, E. C., Weiler, A. M., Haj, A. K., Hatta, M., Chiba, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384917 · Cited by 22
Self-citationLearning the fitness dynamics of pathogens from phylogenies
Lefrancq, N., Duret, L., Bouchez, V., Brisse, S., Parkhill, J., & Salje, H. (2025) · Nature · doi:10.1038/s41586-024-08309-9 · Cited by 21
Al-Mahruqi, S., Wahaibi, A. S. A., Khan, A. L., Al‐Jardani, A., Asaf, S., Al-Kindi, H., Al-Kharusi, S., Al-Rawahi, A. N., Al-Rawahi, A., Al-Salmani, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.049 · Cited by 21
Jeda, A. S., Abbassi, S., Mousavizadeh, A., Esghaie, M., Bokharaei‐Salim, F., Jeddi, F., Shafaati, M., & Abdoli, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108232 · Cited by 22
Spread of endemic SARS-CoV-2 lineages in Russia before April 2021
Klink, G. V., Safina, K. R., Garushyants, S. K., Moldovan, M. A., Nabieva, E., Komissarov, A. B., Lioznov, D. A., & Bazykin, G. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270717 · Cited by 21
Colson, P., Gautret, P., Delerce, J., Chaudet, H., Pontarotti, P., Forterre, P., Tola, R., Bedotto, M., Delorme, L., Bader, W., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28102 · Cited by 23
Monitoring antimicrobial resistance trends from global genomics data: amr.watch
David, S., Caballero, J. D., Couto, N., Abudahab, K., Alikhan, N.-F., Yeats, C., Underwood, A. P., Molloy, A., Connor, D., Shane, H. M., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005256 · Cited by 20
Fatihi, S., Rathore, S., Pathak, A. K., Gahlot, D., Mukerji, M., Jatana, N., & Thukral, L. (2021) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2021.11.002 · Cited by 20
Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico
Taboada, B., Zárate, S., Muñoz‐Medina, J. E., Sánchez‐Flores, A., García-López, R., Herrera‐Estrella, A., Boukadida, C., Gómez‐Gil, B., Mojica, N. S., Rosales-Rivera, M., et al. (2022) · Viruses · doi:10.3390/v14061165 · Cited by 20
Data Integration in Bayesian Phylogenetics
Hassler, G. W., Magee, A. F., Zhang, Z., Baele, G., Lemey, P., Ji, X., Fourment, M., & Suchard, M. A. (2022) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-033021-112532 · Cited by 23
Storti, B., Quaranta, P., Primio, C. D., Clementi, N., Mancini, N., Criscuolo, E., Spezia, P. G., Carnicelli, V., Lottini, G., Paolini, E., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.038 · Cited by 21
Aleta, A., & Moreno, Y. (2020) · medRxiv · doi:10.1101/2020.11.11.20230177 · Cited by 20
Mathavan, S., & Kumar, S. (2020) · Preprints.org · doi:10.20944/preprints202012.0710.v1 · Cited by 20
Richard, D., Shaw, L. P., Lanfear, R., Corbett-Detig, R. B., Hinrichs, A. S., McBroome, J., Turakhia, Y., Acman, M., Owen, C. J., Tan, C. C. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442903 · Cited by 20
Lassaunière, R., Polacek, C., Fonager, J., Bennedbæk, M., Boding, L., Rasmussen, M., & Fomsgaard, A. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.49.2101059 · Cited by 19
Han, A. X., Kozanli, E., Koopsen, J., Vennema, H., RIVM COVID-19 molecular epidemiology group, Hajji, K., Kroneman, A., Walle, I. V., Klinkenberg, D., Wallinga, J., et al. (2022) · eLife · doi:10.7554/elife.78770 · Cited by 19
Wegner, F., Roloff, T. C., Huber, M., Cordey, S., Ramette, A., Gerth, Y., Bertelli, C., Stange, M., Seth-Smith, H. M. B., Mari, A., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01698-21 · Cited by 19
Mallon, P. W. G., Crispie, F., Gonzalez, G., Tinago, W., Leon, A. A. G., McCabe, M. S., de Barra, E., Yousif, O., Lambert, J. S., Walsh, C. J., et al. (2021) · medRxiv · doi:10.1101/2021.02.09.21251402 · Cited by 19
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
Vetter, P., Cordey, S., Schibler, M., Vieux, L., Després, L., Laubscher, F., Andrey, D. O., Martischang, R., Harbarth, S., Cuvelier, C., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.02.010 · Cited by 18
Martínez-García, L., Ruíz, M. A. E., Abreu, M., González‐Alba, J. M., Gijón-Cordero, D., Laso, A. M., Cantón, R., Galán, J. C., & Andrés, J. M. A. (2021) · Microorganisms · doi:10.3390/microorganisms9071517 · Cited by 18
Nguyen, K. V. (2021) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2021.1914851 · Cited by 18
Bollen, N., Artesi, M., Durkin, K., Hong, S. L., Potter, B. I., Boujemla, B., Vanmechelen, B., Martí‐Carreras, J., Wawina-Bokalanga, T., Meex, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97667-9 · Cited by 18
Nocentini, A., Capasso, C., & Supuran, C. T. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2052847 · Cited by 18
Pascall, D. J., Vink, E., Blacow, R., Bulteel, N., Campbell, A., Campbell, R., Clifford, S., Davis, C., Filipe, A. D. S., Sakka, N. E., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284187 · Cited by 18
Huang, D., Liu, Y., Wang, G. A., Lv, S., Tan, Y., & Li, F. (2025) · Chemical Society Reviews · doi:10.1039/d5cs01006c · Cited by 17
Bagherzadeh, M. A., Izadi, M., Baesi, K., Jahromi, M. A. M., & Pirestani, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18152-5 · Cited by 17
Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics
Matteson, N. L., Hassler, G. W., Kurzban, E., Schwab, M. A., Perkins, S. A., Gangavarapu, K., Levy, J. I., Parker, E., Pride, D. T., Hakim, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.024 · Cited by 17
van Hensbergen, M., den Heijer, C. D. J., Wolffs, P. F. G., Hackert, V., ter Waarbeek, H. L. G., Koopmans, M., Sikkema, R. S., Heddema, E. R., & Hoebe, C. J. P. A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06093-9 · Cited by 17
Circulation and Evolution of SARS-CoV-2 in India: Let the Data Speak
Limaye, S., Kasibhatla, S. M., Ramtirthkar, M. R., Kinikar, M., Kale, M. M., & Kulkarni‐Kale, U. (2021) · Viruses · doi:10.3390/v13112238 · Cited by 18
Petrone, M. E., Rothman, J. E., Breban, M. I., Ott, I. M., Russell, A., Lasek‐Nesselquist, E., Badr, H. S., Kelly, K., Omerza, G., Renzette, N., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03347-3 · Cited by 17
Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka
Ranasinghe, D. M. S. H. K., Jayathilaka, D., Jeewandara, C., Gunasinghe, D. N., Ariyaratne, D., Jayadas, T. T. P., Kuruppu, H., Wijesinghe, A., Bary, F., Madusanka, D., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.873633 · Cited by 17
Scalable Bayesian phylogenetics
Fisher, A. A., Hassler, G. W., Ji, X., Baele, G., Suchard, M. A., & Lemey, P. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0242 · Cited by 17
Trobajo‐Sanmartín, C., Miqueleiz, A., Guevara, M., Fernández-Huerta, M., Burgui, C., Casado, I., Baigorría, F., Navascués, A., Ezpeleta, C., & Castilla, J. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac385 · Cited by 17
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
Dingemans, J., van der Veer, B. M. J. W., Gorgels, K. M. F., Hackert, V., Hensels, A. Y. J., den Heijer, C. D. J., Hoebe, C. J. P. A., Savelkoul, P. H. M., & van Alphen, L. B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1027271 · Cited by 19
The immunogenetics of COVID-19
Srivastava, A., & Hollenbach, J. A. (2022) · Immunogenetics · doi:10.1007/s00251-022-01284-3 · Cited by 18
Greco, S., & Gerdol, M. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14672 · Cited by 17
Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes
Jolly, B., Rophina, M., Shamnath, A., Imran, M., Bhoyar, R. C., Divakar, M. K., Rani, P. R., Ranjan, G., Sehgal, P., Chandrasekhar, P., et al. (2020) · doi:10.1101/2020.12.24.424332 · Cited by 17
Lhomme, S., Latour, J., Jeanne, N., Trémeaux, P., Ranger, N., Migueres, M., Salin, G., Donnadieu, C., & Izopet, J. (2021) · Viruses · doi:10.3390/v13122544 · Cited by 16
Fericean, R. M., Cîtu, C., Manolescu, D., Roșca, O., Bratosin, F., Tudorache, E., & Oancea, C. I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102916 · Cited by 16
de Souza, U. J. B., dos Santos, R. N., Campos, F. S., Lourenço, K. L., da Fonseca, F. G., Spilki, F. R., & Corona-ômica.BR/MCTI Network (2021) · Viruses · doi:10.3390/v13091806 · Cited by 16
Phylodynamic Inference of Bacterial Outbreak Parameters Using Nanopore Sequencing
Steinig, E. J., Duchêne, S., Aglua, I., Greenhill, A. R., Ford, R. L., Yoannes, M., Jaworski, J., Drekore, J., Urakoko, B., Poka, H., et al. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac040 · Cited by 16
Marco, C. D., Veneziano, C., Massacci, A., Pallocca, M., Marascio, N., Quirino, A., Barreca, G. S., Giancotti, A., Gallo, L., Lamberti, A. G., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.934993 · Cited by 16
Parker, E., Anderson, C., Zeller, M., Tibi, A., Havens, J. L., Laroche, G., Benlarbi, M., Ariana, A., Robles‐Sikisaka, R., Latif, A. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32536-1 · Cited by 16
Fighting the SARS CoV-2 (COVID-19) Pandemic with SoapPreprint
Chaudhary, N. K., Chaudhary, N., Dahal, M., Guragain, B., Rai, S., Chaudhary, R., Sachin, K. M., Lamichhane-Khadka, R., & Bhattarai, A. (2021) · Preprints.org · doi:10.20944/preprints202005.0060.v3 · Cited by 16
Metadata
- Authors
- Hodcroft, E. B., Zuber, M., Nadeau, S., Vaughan, T. G., Crawford, K. H. D., Althaus, C. L., Reichmuth, M. L., Bowen, J. E., Walls, A. C., Corti, D., Bloom, J. D., Veesler, D., Mateo, D., Hernando, A., Comas, I., González-Candelas, F., SeqCOVID-SPAIN consortium, González-Candelas, F., Goig, G. A., Chiner-Oms, Á., Cancino-Muñoz, I., López, M. G., Torres-Puente, M., Gomez-Navarro, I., Jiménez-Serrano, S., Ruiz-Roldán, L., Bracho, M. A., García-González, N., Martínez-Priego, L., Galán-Vendrell, I., Ruiz-Hueso, P., De Marco, G., Ferrús, M. L., Carbó-Ramírez, S., D’Auria, G., Coscollá, M., Ruiz-Rodríguez, P., Roig-Sena, F. J., Sanmartín, I., Garcia-Souto, D., Pequeno-Valtierra, A., Tubio, J. M. C., Rodríguez-Castro, J., Rabella, N., Navarro, F., Miró, E., Rodríguez-Iglesias, M., Galán-Sanchez, F., Rodriguez-Pallares, S., de Toro, M., Escudero, M. B., Azcona-Gutiérrez, J. M., Alberdi, M. B., Mayor, A., García-Basteiro, A. L., Moncunill, G., Dobaño, C., Cisteró, P., García-de-Viedma, D., Pérez-Lago, L., Herranz, M., Sicilia, J., Catalán-Alonso, P., Muñoz, P., Muñoz-Cuevas, C., Rodríguez-Rodríguez, G., Alberola-Enguidanos, J., Nogueira, J. M., Camarena, J. J., Rezusta, A., Tristancho-Baró, A., Milagro, A., Martínez-Cameo, N. F., Gracia-Grataloup, Y., Martró, E., Bordoy, A. E., Not, A., Antuori-Torres, A., Benito, R., Algarate, S., Bueno, J., del Pozo, J. L., Boga, J. A., Castelló-Abietar, C., Rojo-Alba, S., Alvarez-Argüelles, M. E., Melon, S., Aranzamendi-Zaldumbide, M., Vergara-Gómez, A., Fernández-Pinero, J., Martínez, M. J., Vila, J., Rubio, E., Peiró-Mestres, A., Navero-Castillejos, J., Posada, D., Valverde, D., Estévez-Gómez, N., Fernandez-Silva, I., de Chiara, L., Gallego-García, P., Varela, N., Moreno, R., Tirado, M. D., Gomez-Pinedo, U., Gozalo-Margüello, M., Eliecer-Cano, M., Méndez-Legaza, J. M., Rodríguez-Lozano, J., Siller, M., Pablo-Marcos, D., Oliver, A., Reina, J., López-Causapé, C., Canut-Blasco, A., Hernáez-Crespo, S., Cordón, M. L. A., Lecároz-Agara, M.-C., Gómez-González, C., Aguirre-Quiñonero, A., López-Mirones, J. I., Fernández-Torres, M., Almela-Ferrer, M. R., Gonzalo-Jiménez, N., Ruiz-García, M. M., Galiana, A., Sanchez-Almendro, J., Cilla, G., Montes, M., Piñeiro, L., Sorarrain, A., Marimón, J. M., Gomez-Ruiz, M. D., López-Hontangas, J. L., González Barberá, E. M., Navarro-Marí, J. M., Pedrosa-Corral, I., Sanbonmatsu-Gámez, S., Pérez-González, C., Chamizo-López, F., Bordes-Benítez, A., Navarro, D., Albert, E., Torres, I., Gascón, I., Torregrosa-Hetland, C. J., Pastor-Boix, E., Cascales-Ramos, P., Fuster-Escrivá, B., Gimeno-Cardona, C., Ocete, M. D., Medina-Gonzalez, R., González-Cantó, J., Martínez-Macias, O., Palop-Borrás, B., de Toro, I., Mediavilla-Gradolph, M. C., Pérez-Ruiz, M., González-Recio, Ó., Gutiérrez-Rivas, M., Simarro-Córdoba, E., Lozano-Serra, J., Robles-Fonseca, L., de Salazar, A., Viñuela-González, L., Chueca, N., García, F., Gómez-Camarasa, C., Carvajal, A., de la Puente, R., Martín-Sánchez, V., Fregeneda-Grandes, J.-M., Molina, A. J., Argüello, H., Fernández-Villa, T., Farga-Martí, M. A., Domínguez-Márquez, V., Costa-Alcalde, J. J., Trastoy, R., Barbeito-Castiñeiras, G., Coira, A., Pérez-del-Molino, M. L., Aguilera, A., Planas, A. M., Soriano, A., Fernandez-Cádenas, I., Pérez-Tur, J., Marcos, M. Á., Moreno-Docón, A., Viedma, E., Mingorance, J., Galán-Montemayor, J. C., Parra-Grande, M., Stadler, T., & Neher, R. A.
- Affiliations
- University of Bern (CH)
- University of Basel (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- University of Washington (US)
- Vir Biotechnology (Switzerland) (CH)
- Howard Hughes Medical Institute (US)
- Consejo Superior de Investigaciones Científicas (ES)
- Universitat de València (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital San Pedro de Alcántara (ES)
- Universidad de Zaragoza (ES)
- Hospital Universitario Miguel Servet (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Servicio Gallego de Salud (ES)
- Universidade de Vigo (ES)
- Marqués de Valdecilla University Hospital (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Universitario Son Espases (ES)
- Osakidetza (ES)
- Hospital General Universitario de Elche (ES)
- Biogipuzkoa Health Research Institute (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- INCLIVA Health Research Institute (ES)
- Hospital General de Elda (ES)
- Hospital General Universitario De Valencia (ES)
- Hospital Regional Universitario de Málaga (ES)
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (ES)
- Hospital General Universitario de Albacete (ES)
- Universidad de León (ES)
- Hospital Arnau de Vilanova (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario La Paz (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Hospital Marina Baixa (ES)
- Corresponding author
- Hodcroft, Emma B.
- Neher, Richard A.
- ORCID
- Hodcroft, Emma B.
- Zuber, Moira
- Nadeau, Sarah
- Vaughan, Timothy G.
- Crawford, Katharine H. D.
- Althaus, Christian L.
- Reichmuth, Martina L.
- Bowen, John E.
- Walls, Alexandra C.
- Corti, Davide
- Bloom, Jesse D.
- Veesler, David
- Mateo, David
- Hernando, Alberto
- Comas, Iñaki
- López, Mariana Gabriela
- Jiménez-Serrano, Santiago
- Bracho, María Alma
- Ruiz-Hueso, Paula
- Carbó-Ramírez, Sandra
- D’Auria, Giuseppe
- Coscollá, Mireia
- Ruiz-Rodríguez, Paula
- Sanmartín, Isabel
- Navarro, Ferrán
- Miró, Elisenda
- Mayor, Alfredo
- Moncunill, Gemma
- Dobaño, Carlota
- Cisteró, Pau
- Sicilia, Jon
- Camarena, Juan José
- Rezusta, Antonio
- Tristancho-Baró, Alexander
- Milagro, Ana
- Martró, Elisa
- Bordoy, Antoni E.
- Not, Anna
- Benito, Rafael
- Algarate, Sonia
- Bueno, Jessica
- Martínez, Miguel J.
- Peiró-Mestres, Aida
- Posada, David
- Valverde, Diana
- Varela, Nair
- Gozalo-Margüello, Mónica
- Méndez-Legaza, José Manuel
- Siller, María
- Oliver, Antonio
- Reina, Jordi
- López-Causapé, Carla
- Aguirre-Quiñonero, Amaia
- Almela-Ferrer, Maria Rosario
- Gonzalo-Jiménez, Nieves
- Galiana, Antonio
- Cilla, Gustavo
- Montes, Milagrosa
- Piñeiro, Luis
- Sorarrain, Ane
- Marimón, José María
- Pedrosa-Corral, Irene
- Chamizo-López, Francisco
- Navarro, David
- Albert, Eliseo
- Torres, Ignacio
- Gimeno-Cardona, Concepción
- Medina-Gonzalez, Rafael
- Palop-Borrás, Begoña
- Pérez-Ruiz, Mercedes
- González-Recio, Óscar
- Chueca, Natalia
- Carvajal, Ana
- Molina, Antonio José
- Argüello, Héctor
- Costa-Alcalde, José Javier
- Trastoy, Rocío
- Coira, Amparo
- Aguilera, Antonio
- Planas, Anna M.
- Viedma, Esther
- Mingorance, Jesús
- Parra-Grande, Mónica
- Stadler, Tanja
- Neher, Richard A.
- Venue
- Nature
- Published
- 2021-06-07
- Volume
- 595
- Issue
- 7869
- Pages
- 707-712
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3166766123
- Semantic Scholar
- 2469490cde7d14d5793b659c17202c99169479ec
- Cited by
- 425
- References
- 47
- Citations by year
- 2026: 12 · 2025: 34 · 2024: 53 · 2023: 80 · 2022: 128 · 2021: 115
- FWCI
- 29.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- Buleria (Universidad de León) (submittedVersion, cc-by-nc-nd)
- RePEc: Research Papers in Economics (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, other-oa)
- Zaguan (University of Zaragoza Repository) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Burroughs Wellcome Fund
- Universität Basel
- Fast Grants
- European Commission (HORIZON2020, 101003688, COVID-19)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196046, 196267)
- Bundesamt für Gesundheit
- Eidgenössische Technische Hochschule Zürich
- Consejo Superior de Investigaciones Científicas
- Instituto de Salud Carlos III (COV20, COV20/00140)
- National Institute of General Medical Sciences (R01GM120553)
- National Institute of Allergy and Infectious Diseases (HHSN272201700059C, COVID-19, DP1AI158186, F30AI149928, R01AI141707)
- H2020 European Research Council (638553)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, international travel, viral spread, genomic surveillance, travel restrictions, containment strategies, transmissibility, summer 2020, Europe, Spain
- MeSH terms
- COVID-19, SARS-CoV-2, Europe, Genotype, Humans, Phylogeny, Seasons, Time Factors, Travel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
